Chemotherapy, the standard cancer treatment, is largely prescribed by informed guesses. Because this inaccurate method kills both cancerous and healthy cells, patients suffer from nasty side effects and don’t usually get a drug that works for them the first time, if they get one that works at all.
We’re developing a targeted therapy for a highly lethal leukemia and a diagnostic to determine which patients will respond well to the drug.
We’re ready to start Phase 1b/2 of clinical trials with leading hematology oncology experts.
